A Non-Conventional Pathway to Commercialize an EV Therapeutic

By | 19 March 2026
  • MSC secretome: Cell therapy without the cells
  • Navigating Direct Biologics’ pathway to phase III clinical trial
  • Leveraging nature’s mechanism of action for disease mitigation

NEW DATA!